Viewing Study NCT06789159


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-01-29 @ 10:13 AM
Study NCT ID: NCT06789159
Status: RECRUITING
Last Update Posted: 2025-10-20
First Post: 2025-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Sponsor: Thomas Jefferson University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B Cell Lymphoma Refractory View
None Diffuse Large B Cell Lymphoma Relapsed View
None Epstein-Barr Virus (EBV) Infection View
Keywords: